HLA Class II Tissue Typing for Donor at Chughtai Lab

HLA Class II Tissue Typing for Donor at Chughtai Lab

HLA Class II Tissue Typing for Donor at Chughtai Lab is a highly specialized molecular diagnostic test designed to evaluate the compatibility between an organ or stem cell donor and a recipient. Human Leukocyte Antigens (HLA) are proteins located on the surface of most cells in the body, playing a critical role in the immune system’s ability to distinguish self from non-self. While Class I HLA antigens (HLA-A, HLA-B, and HLA-C) are found on all nucleated cells, Class II HLA antigens (specifically HLA-DR, HLA-DQ, and HLA-DP) are primarily expressed on antigen-presenting cells, such as B lymphocytes, dendritic cells, and macrophages. Identifying these specific genetic markers is a foundational requirement in transplant medicine, as it directly influences the immunological success of the transplant, the risk of graft rejection, and the development of graft-versus-host disease (GVHD).

At Chughtai Lab, this test is performed using advanced molecular biology techniques, such as Polymerase Chain Reaction (PCR) combined with Sequence-Specific Primers (PCR-SSP) or Next-Generation Sequencing (NGS). These state-of-the-art technologies allow for high-resolution typing, which identifies the exact alleles present in the donor’s genome. This level of precision is vital for bone marrow and hematopoietic stem cell transplants, where even a single amino acid mismatch in the HLA Class II binding groove can trigger a severe, life-threatening immune response. For solid organ transplants, such as kidney or liver transplants, accurate HLA Class II typing helps predict the risk of antibody-mediated rejection, enabling transplant surgeons and nephrologists to design optimal immunosuppressive regimens.

Clinical Procedure: What to Expect

Patient Preparation

Preparing for the HLA Class II Tissue Typing for Donor at Chughtai Lab is straightforward, as it is a laboratory-based molecular test. Patients and donors should observe the following guidelines to ensure a smooth sample collection process:

• No Fasting Required: There is no need to fast before this test. Donors can eat and drink normally prior to their appointment.
• Medication Disclosure: Inform the healthcare provider about all current medications, especially immunosuppressants, chemotherapy agents, or recent blood transfusions, as these can occasionally influence sample cellularity or molecular analysis.
• Hydration: Staying well-hydrated is recommended, as it makes the venipuncture process easier and more comfortable.
• Identification and Documentation: Because this test is legally and clinically critical for transplant matching, donors must bring official identification (such as a CNIC or passport) and transplant referral documents to the Chughtai Lab collection center.

During the Procedure

The sample collection process is quick, safe, and performed by experienced phlebotomists at Chughtai Lab:

• Sanitization and Setup: The phlebotomist will sanitize the collection site, typically the inner elbow, using an antiseptic swab.
• Venipuncture: A sterile, single-use needle is inserted into a vein to draw a blood sample. The blood is collected in specialized tubes containing ethylenediaminetetraacetic acid (EDTA) or acid citrate dextrose (ACD), which prevent clotting and preserve the integrity of the white blood cells and genomic DNA.
• Alternative Sampling: In rare cases where venipuncture is not feasible, a buccal (cheek) swab may be used to collect epithelial cells for DNA extraction, though blood is the preferred specimen.
• Duration: The entire blood draw takes less than five minutes.
• Post-Collection Care: A small bandage is applied to the puncture site. Donors can immediately resume their daily activities.

When is an HLA Class II Tissue Typing for Donor Performed?

Renal Transplantation Compatibility Assessment

Renal transplantation is the gold-standard treatment for end-stage renal disease (ESRD). Physicians request HLA Class II Tissue Typing for potential kidney donors to compare their HLA-DR and HLA-DQ loci with those of the recipient. A close match at these loci significantly reduces the likelihood of the recipient developing donor-specific antibodies (DSA), which are a primary cause of chronic allograft nephropathy and long-term graft loss.

Hematopoietic Stem Cell and Bone Marrow Donor Matching

For patients suffering from leukemia, lymphoma, aplastic anemia, or severe thalassemia, a bone marrow or hematopoietic stem cell transplant offers a potential cure. HLA Class II typing is absolutely mandatory for prospective donors in these cases. Because the donor’s immune cells will populate the recipient’s body, a high-resolution match at the HLA-DRB1 and HLA-DQB1 loci is critical to prevent graft-versus-host disease, where the transplanted cells attack the recipient’s tissues.

Liver and Cardiothoracic Transplant Evaluation

While liver transplants are less dependent on strict HLA matching due to the liver’s unique immunotolerance, HLA Class II typing is still performed for living liver donors. It helps assess the baseline immunological risk and guides post-transplant immunosuppressive therapy. For heart and lung transplants, matching HLA Class II antigens helps minimize the risk of acute cellular rejection and antibody-mediated graft injury.

Identifying Pre-existing Donor-Specific Antibodies

Before a transplant can proceed, clinicians must determine if the recipient has pre-existing antibodies against the donor’s HLA Class II antigens. Performing HLA typing on the donor allows the laboratory to conduct a virtual crossmatch. If the recipient has antibodies targeting the donor’s specific HLA-DR or DQ alleles, the transplant is classified as high-risk, and desensitization protocols or an alternative donor must be sought.

Familial Donor Screening and Registry Matching

When a patient requires a transplant, immediate family members (siblings, parents, and children) are screened first. HLA Class II typing is performed on these potential familial donors to identify haploidentical (half-matched) or fully matched individuals. Siblings have a 25 percent chance of being a perfect HLA match. If no familial match is found, the donor’s HLA profile can be used to search national and international bone marrow donor registries.

What Does an HLA Class II Tissue Typing for Donor Detect?

HLA Class II Tissue Typing for Donor at Chughtai Lab utilizes advanced molecular assays to detect and identify specific genetic alleles. The test evaluates several key parameters, including:

• HLA-DRB1 Alleles: Detects the highly polymorphic alleles of the beta 1 chain of the HLA-DR molecule, which is the most critical locus for transplant matching.
• HLA-DRB3, DRB4, and DRB5 Loci: Identifies the presence of these secondary HLA-DR beta chain genes, which can influence immune recognition.
• HLA-DQB1 Alleles: Determines the specific alleles encoding the beta chain of the HLA-DQ molecule, essential for assessing renal transplant compatibility.
• HLA-DQA1 Alleles: Identifies the alpha chain alleles of the HLA-DQ molecule, which pair with DQB1 to form the functional receptor.
• HLA-DPB1 Alleles: Evaluates the beta chain of the HLA-DP antigen, particularly useful in high-resolution bone marrow donor matching.
• HLA-DPA1 Alleles: Detects the alpha chain alleles of the HLA-DP molecule.
• Low-Resolution Antigen Groups: Identifies broad HLA antigen families (e.g., HLA-DR4 or HLA-DR15), suitable for initial donor screening.
• High-Resolution Allele Typing: Identifies specific nucleotide sequences and amino acid variations (e.g., HLA-DRB1*04:01), critical for stem cell transplants.
• Haplotype Sharing: Determines the inherited set of HLA genes from each parent, helping map familial inheritance patterns.
• Null Alleles: Detects genetic variants that do not express functional proteins on the cell surface, preventing false-positive match assumptions.
• Synonymous and Non-Synonymous Mutations: Identifies genetic variations within the HLA coding regions.
• Sequence-Specific Primer (SSP) Binding: Detects the presence of target DNA sequences through successful PCR amplification.
• Sequence-Specific Oligonucleotide (SSO) Hybridization: Identifies HLA alleles based on the binding of labeled probes to amplified DNA.
• Next-Generation Sequencing (NGS) Reads: Provides clonal sequence data for ultimate resolution and allele definition.
• Donor-Recipient Mismatch Count: Quantifies the exact number of mismatched alleles between the donor and recipient (e.g., 1-allele mismatch, 2-allele mismatch).
• Permissive vs. Non-Permissive Mismatches: Helps classify HLA-DPB1 mismatches that are immunologically tolerated (permissive) versus those likely to trigger rejection (non-permissive).
• Epitope Matching (Epitypes): Analyzes specific structural patches on the HLA molecule rather than the whole allele, offering a modern approach to compatibility.
• Antigenic Split Identification: Differentiates closely related sub-types of HLA antigens.
• Maternal Haplotype Markers: Identifies the HLA genes inherited from the donor’s mother.
• Paternal Haplotype Markers: Identifies the HLA genes inherited from the donor’s father.

Turnaround Time and Report Access at Chughtai Lab

Because HLA Class II Tissue Typing involves complex molecular DNA extraction, amplification, and sequencing, the turnaround time is longer than standard blood tests. Typically, results are available within 5 to 7 working days. Chughtai Lab is committed to delivering highly accurate, double-verified reports. Patients and transplant coordinators can easily access reports online through the official Chughtai Lab website or the Chughtai Lab mobile app. Additionally, reports can be collected from any of the numerous Chughtai Lab diagnostic centers located across Pakistan, or delivered via email.

HLA Class II Tissue Typing Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HLA-DRB1 Locus	Clear identification of two maternal/paternal alleles (e.g., DRB1*03:01, DRB1*15:01)	Presence of rare alleles, null alleles, or complete mismatch with the recipient
HLA-DQB1 Locus	Successful typing of DQB1 alleles (e.g., DQB1*02:01, DQB1*06:02)	Mismatches that increase the risk of donor-specific antibody (DSA) formation
HLA-DPB1 Locus	Identification of DPB1 alleles; permissive mismatch with recipient	Non-permissive DPB1 mismatch, indicating high risk of graft-versus-host disease
Haplotype Matching	50% match (1 haplotype) with parents/children; 100% match (2 haplotypes) with identical sibling	0% match (0 haplotypes) indicating high immunological barrier for transplant
Allele Resolution	High-resolution four-digit or six-digit allele definition achieved	Low-resolution typing insufficient for bone marrow donor clearance
DNA Quality & Quantity	High-purity genomic DNA extracted from donor sample	Degraded DNA or low yield requiring a repeat sample collection
Null Alleles (e.g., DRB1*04:01:01:02N)	Absence of null alleles; normal cell surface expression of HLA Class II	Presence of null allele, meaning the typed gene does not produce a functional antigen

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for HLA Class II Tissue Typing?

• Experienced Healthcare Professionals: Chughtai Lab employs highly qualified molecular biologists, pathologists, and laboratory technologists specializing in immunogenetics.
• Patient-Focused Care: The staff provides compassionate, professional support to donors and patients throughout the transplant workup.
• Quality Diagnostic Services: Chughtai Lab adheres to international quality standards, ensuring highly reliable and reproducible molecular results.
• Professional Reporting: Reports are detailed, clear, and structured to provide transplant teams with the exact allele data they need.
• Modern Diagnostic Approach: Utilizing state-of-the-art PCR and sequencing platforms to deliver high-resolution HLA typing.
• Comfortable Environment: All collection centers are designed to offer a clean, safe, and stress-free experience for donors.
• Convenient Location: With an extensive network of diagnostic centers across Pakistan, finding a nearby Chughtai Lab is easy.
• Commitment to Accurate Diagnosis: Strict internal and external quality control protocols guarantee the clinical validity of every HLA test.